TRVI - Trevi Therapeutics Inc Qarzning balans kapitallashuviga nisbati
Trevi Therapeutics (TRVI) kompaniyasining kunlik narxlar grafigi kirish to'siqlari qat'iy FDA nazorati va qimmatbaho ishlanmalar bilan belgilanadigan aktivni ifodalaydi. Trevi Therapeutics rahbariyati nomzodlarni doimiy ravishda yakuniy sinovlar bosqichiga olib chiqmoqda va joriy ko'rsatkich 0.00 darajasida turibdi. Biznes yo'tal va qichishishga qarshi dori vositalarini ishlab chiqishga, shuningdek, tor doiradagi tibbiy segmentlarda o'pka va jigar patologiyalariga chalingan bemorlarning ehtiyojlarini qondirishga asoslangan.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_TRVI_-_Trevi-Therapeutics_-_Debt-to-Net-Assets-Ratio "Trevi Therapeutics, Inc. - TRVI Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Trevi Therapeutics Inc (TRVI) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Trevi Therapeutics|TRVI - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Trevi Pharma|TRVI - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Trevi Corp|TRVI - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzlari Trevi Therapeutics
Kompaniyaning barcha koʻrsatkichlari tahlili:TRVI (Trevi Therapeutics)
Investorlar Trevi Therapeutics (TRVI) kompaniyasini Haduvio ning kelajakdagi tijoratlashtirish prizmasi orqali baholamoqdalar, bunda barqaror daromadga erishilgunga qadar moliyaviy barqarorlik hal qiluvchi ahamiyatga ega bo'lib qolmoqda. Jami majburiyatlarning kitob kapitalizatsiyasiga nisbatini tahlil qilish orqali qarzlar moddiy aktivlar bilan qanchalik qoplanishini aniqlash mumkin, bu esa kompaniyaning kritik qarz yukisiz innovatsiyalarni qo'llab-quvvatlash qobiliyatini tasdiqlagan holda, bozor tebranishlari va haqiqiy bankrotlik xavfi o'rtasidagi farqni ajratish imkonini beradi.
Trevi Therapeutics raqobatchilari
Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|Balans qiymatiga qarzlar Xenon Corp|Viking Therapeutics (VKTX) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati SUPN|Catalyst Pharmaceuticals, Inc. (CPRX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati Denali (DNLI)|HRMY: Balans kapitallashuviga qarzlar|BHVN - Balans qiymatiga qarzlar|AMLX - Qarzning balans qiymatiga nisbati|PRAX - Qarzning balans kapitallashuviga nisbati|Anavex Life Sciences Corp. - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar CeriBell Inc|PRTA - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Alector Therapeutics (ALEC)|Qarzning balans qiymatiga nisbati Annexon, Inc.|Qarzning balans kapitaliga nisbati omeros.com (OMER)|Balans kapitallashuviga qarzlar Neurogene|Qarzning sof aktivlarga nisbati AC Immune S.A. ACIU|VYGR (Voyager Pharma) - Balans kapitallashuviga qarzlar|NMRA: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Scilex Holding Company SCLX|tevogen.com (TVGN) - Qarzning sof aktivlarga nisbati|ACOG (Alpha Cognition Inc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar CGTX|IKT - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Cassava Pharma (SAVA)|ASRT: Balans kapitallashuviga qarzlar|COYA - Balans qiymatiga qarzlar|VistaGen Therapeutics Inc - Qarzning balans qiymatiga nisbati|Ovid Therapeutics Inc. (OVID) - Balans kapitallashuviga qarzlar|ABOS - Qarzning balans qiymatiga nisbati|CervoMed Corporation (CRVO) - Qarzning balans kapitaliga nisbati|ATHE: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Clene Nanomedicine|Balans kapitallashuviga qarzlar PEPG (PepGen Inc.)|Qarzning balans qiymatiga nisbati JUNS (Jupiter Neurosciences, Inc.)|Qarzning balans kapitallashuviga nisbati RLMD|ANVS - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati Grace Tx GRCE|AIFF: Qarzning balans kapitaliga nisbati|Qarzning balans kapitallashuviga nisbati anewmeds.com KLTO|Qarzning sof aktivlarga nisbati NeuroSense Therapeutics Ltd.|Qarzning balans qiymatiga nisbati Reviva Pharmaceuticals Holdings|Qarzning balans kapitallashuviga nisbati MetaVia, Inc.|NRXS (NeurAxis, Inc.) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar HSDT (heliusmedical.com)|PASG - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Neuphoria Therapeutics, Inc. NEUP|NERV (Minerva Neurosciences Corp) - Balans kapitallashuviga qarzlar|Athira Pharma Corp (ATHA) - Balans qiymatiga qarzlar|ADXN: Qarzning balans qiymatiga nisbati|ALZN (Alzamend Neuro) - Balans kapitallashuviga qarzlar|CYCN - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati PTIX|Pasithea Therapeutics - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar cortigent.com CRGT|Qarzning balans qiymatiga nisbati Avenue Therapeutics (ATXI)|brainstorm-cell.com - Qarzning balans kapitaliga nisbati|Qarzning balans kapitallashuviga nisbati Cara Therapeutics (CARA)|CHRO - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar ELYM|Balans qiymatiga qarzlar Intra-Cellular Therapies, Inc.|Qarzning balans qiymatiga nisbati Longboard Pharmaceuticals|Qarzning balans kapitallashuviga nisbati marinuspharma.com|NKGN (NKGen Biotech) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar NeuroBo Pharmaceuticals Inc NRBO|Qarzning balans qiymatiga nisbati Sage Therapeutics, Inc|SNPX - Qarzning sof aktivlarga nisbati|Qarzning balans qiymatiga nisbati Trevena, Inc. TRVN|VIGL - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Anew Medical WENA|Cerevel Therapeutics Inc (CERE) - Qarzning sof aktivlarga nisbati